Medical Weight Loss for Meridian, Mississippi Residents

Meridian, Mississippi residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Meridian through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Meridian: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Mississippi patients choose. Doctor review just $119 (medication separate).

Why Meridian Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Meridian, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Mississippi for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

Meridian is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Meridian address.

People throughout Meridian reach the same physician-supervised care that built our reputation in Costa Mesa, and they do it from home, because telehealth erases the gap between Mississippi and California. We care for patients throughout downtown Meridian and the greater Lauderdale County area of east Mississippi. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Meridian, even on warm Mississippi afternoons.

You can start this week from anywhere in Mississippi, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Meridian patients. New Hope Weight Loss serves patients across Mississippi entirely by telehealth from our Costa Mesa, California clinic, so the same physician care reaches every part of the state.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Meridian choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Meridian

Step 1: The quiz. Tell us about your health history, current weight, and goals through a quick online intake.

Step 2: The video visit. Dr. Sharma reviews your intake and meets you by secure video, usually within 48 hours, to discuss whether compounded semaglutide or tirzepatide is a fit. Results vary from person to person.

Step 3: Delivery. A state-licensed 503(a) pharmacy ships your medication to your Meridian address in cold-pack packaging.

Step 4: Follow-ups. You stay in touch by video as you progress.

Frequently Asked Questions, Meridian

Where is the New Hope Weight Loss location serving Meridian?

The location serving Meridian is our Costa Mesa, California clinic, which is our only physical site. We care for Meridian, Mississippi patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Meridian patients?

It is the standard for Meridian. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Meridian in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Meridian patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Meridian patients.

What areas of Meridian do you serve?

We serve patients from across Meridian by telehealth, including downtown Meridian and the greater Lauderdale County area of east Mississippi.

Are there hidden fees for Meridian patients?

No. Meridian patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Meridian Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Meridian, Mississippi by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.